Recently, the world’s focus shifted to Dogecoin (DOGE) since Grayscale and Bitwise started advocating for a Dogecoin exchange-traded fund (ETF). If this were to push through, we could see many more institutional buyers due to its growing potential, increasing the market cap to an astonishing $500 billion. Nevertheless, as exciting as it sounds, most analysts are looking toward Dogecoin’s altcoin competition. Rexas Finance (RXS) seems to be leading the path with the most significant opportunities in the market for real-world asset tokenization.

最近，自Grayscale和Bitwise开始倡导Dogecoin交换基金（ETF）以来，世界的重点转移到了Dogecoin（Doge）。如果要通过，我们可以看到更多的机构买家的潜力越来越大，将市值增加到了令人惊讶的5000亿美元。尽管如此，尽管听起来令人兴奋，但大多数分析师都在寻求Dogecoin的Altcoin竞赛。 Rexas Finance（RXS）似乎在现实世界中最重要的机遇方面正在领先这一道路。

The Race for the Dogecoin ETF – A Paradigm Shift or More of the Same?

Dogecoin ETF的竞赛 - 范式转变或更多相同？

The talk and focus on the Dogecoin ETF are starting to increase, capturing the interest of more investors. As of mid-February, the SEC confirmed receipt of Grayscale’s document submission on February 14, 2025, which was greatly unpublicized. Maybe now there is a reason for excitement, as DOGE’s price surpassed $0.27. If the ETF does receive approval, it will boost institutional investment, similar to how Bitcoin and Ethereum ETFs did. Analysts at Bloomberg have projected a 75% likelihood of approval for the Dogecoin ETF this year, which is higher than Solana’s projection of 70%. Should the approval go through, Dogecoin could witness tremendous growth beyond its all-time high of $0.48 in December 2024 and reach the $1 range.

对Dogecoin ETF的谈话和关注开始增加，从而吸引了更多的投资者的兴趣。截至2月中旬，美国证券交易委员会（SEC）确认在2025年2月14日收到了格雷斯卡（Grayscale）的文件提交，该文件大为未知。也许现在有一个兴奋的理由，Doge的价格超过了0.27美元。如果ETF确实获得批准，它将促进机构投资，类似于比特币和以太坊ETF的表现。彭博社的分析师预计，今年Dogecoin ETF的批准可能性为75％，高于Solana的70％的预测。如果获得批准，Dogecoin可能会目睹2024年12月其历史最高高点的巨大增长，并达到1美元的范围。

However, despite the optimism surrounding the ETF, most analysts are looking toward Dogecoin’s altcoin competition. Rexas Finance (RXS) stands out with the most significant opportunities in the market for real-world asset tokenization.

但是，尽管围绕ETF充满乐趣，但大多数分析师都在寻求Dogecoin的Altcoin竞争。 Rexas Finance（RXS）脱颖而出，在现实世界中最重要的机遇中脱颖而出。

Rexas Finance (RXS): The Altcoin Analysts’ Favorite Pick

Rexas Finance（RXS）：Altcoin分析师最喜欢的选秀

While the focus remains on Dogecoin, wiser investors are considering Rexas Finance (RXS) as a more viable option. Unlike DOGE, which relies more on speculation and hype, RXS is entrenched in the to-be concept of RWA or Real-World Asset Tokenization. In its last presale stage (Stage 12), the RXS presale price is $0.20. So far, it has raised $46.5 million and sold 252.9 million tokens. The presale is 90.58% complete, and the token will be listed on major exchanges at $0.25 on June 19, 2025.

虽然重点仍然放在狗狗币上，但明智的投资者将Rexas Finance（RXS）视为一个更可行的选择。与Doge不同的是，更多的是投机和炒作，RXS是在RWA或现实世界资产令牌的概念中根深蒂固的。在最后的预售阶段（第12阶段），RXS预售价格为0.20美元。到目前为止，它已经筹集了4650万美元，售出了2.529亿个令牌。预售已完成90.58％，代币将在2025年6月19日的0.25美元的主要交易所上市。

Why RXS Is the Smarter Investment Over DOGE

为什么RXS是对Doge的智能投资

The tokenization of real-world assets has recently become an increasingly adopted trend in blockchain technology. RXS allows investors to purchase a fraction of a high-value item, such as real estate or a commodity, without brokers, significantly increasing market liquidity. This use case gives RXS an edge over Dogecoin and other meme-based currencies. Additionally, institutional investors are looking into RWA tokenization as a hedge against inflation and volatility in traditional markets.

现实世界中资产的令牌化最近已成为区块链技术越来越多的趋势。 RXS允许投资者购买一小部分高价值商品，例如房地产或商品，而无需经纪人，大大增加了市场流动性。此用例使RXS比Dogecoin和其他基于模因的货币具有优势。此外，机构投资者正在研究RWA令牌化，以对冲传统市场的通货膨胀和波动性。

With RXS undergoing the presale and clear regulatory frameworks emerging for asset-backed tokens, RXS will experience increased demand and moderate price volatility after the listing.

随着RX经历了用于资产支持的代币的预售和清晰的监管框架，RXS将经历上市后的需求增加和中等价格波动。

Possible Price Movement for RXS and DOGE

RXS和DOGE的可能价格转移

According to reports, the price of Dogecoin is expected to reach around $1 in late 2025. However, with the ETF’s conditionality on hype cycles and the meme coin’s levity, it poses a high-risk asset with a negative long-term prognosis.

据报道，狗狗蛋白的价格预计在2025年底将达到1美元左右。但是，由于ETF对炒作循环的条件性和模因硬币的有条件的条件，它构成了一个高风险的资产，具有负长期预后。

On the other hand, RXS has a more defined growth structure with the additional support of a functioning product. Analysts predict that RXS could rally from $0.25 at the upcoming exchange listing to $5 in the short term and potentially $20 within two years.

另一方面，RXS在功能性产品的额外支持下具有更明确的生长结构。分析师预测，RXS可以从即将到来的交易所上市的0.25美元上升到短期内的5美元，并在两年内可能会在20美元中。

To put this into perspective, a $5 price target for RXS could be reached by early 2026, considering that the token will be listed on major exchanges at $0.25 on June 19, 2025.

考虑到这一点，考虑到代币将在2025年6月19日的0.25美元上列出，RXS可以在2026年初达到5美元的RXS目标。

At the current presale price of $0.2, a 25x increase in value is possible if the token reaches $5, and a 100x return if it hits $20, which is certainly far greater than the opportunity Dogecoin provides.

以目前的预售价格为0.2美元，如果代币达到5美元，则可能增加25倍的价值，如果达到20美元，则可以将100倍的回报率提高，这肯定远远大于Dogecoin提供的机会。

Considering the ETF push, Dogecoin’s valuation could rise significantly. However, how long it will last is an entirely different question. Due to the social media-driven characteristics of meme coins, they greatly alter the risks serious investors take. On the other hand, RXS makes for a more appealing investment, especially with its technology in asset tokenization. People searching for crypto investments with high growth potential need to look no further than RXS.

考虑到ETF的推动，Dogecoin的估值可能会大大提高。但是，它将持续多长时间是一个完全不同的问题。由于模因硬币的社交媒体驱动特征，它们会大大改变严重的投资者承担的风险。另一方面，RXS进行了更具吸引力的投资，尤其是在其资产令牌技术方面。寻找具有较高增长潜力的加密投资的人们只需要看RXS。

As institutional interest in RWA tokenization rises, Rexas Finance (RXS) will surpass Dogecoin’s growth rate, possibly becoming one of the best-performing tokens of 2025 and beyond. Considering it is set to be listed on

随着RWA令牌化的机构兴趣的增加，Rexas Finance（RXS）将超过Dogecoin的增长率，可能成为2025年及以后表现最好的代币之一。考虑到它被设置为